SCHEMBL5373328

SCHEMBL5373328

COc1cc(Br)c(O)c(C=C2C(=O)Nc3ccc(Br)c(C)c32)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 2/20 0.52
MDM2 Q00987 4/20 0.46
RAF1 P04049 6/20 0.42
AURKA O14965 1/20 0.42
MAP1LC3B Q9GZQ8 3/20 0.39
PLK4 O00444 2/20 0.39
PLK1 P53350 2/20 0.39
PSEN1 P49768 1/20 0.39
PSEN2 P49810 1/20 0.39
APH1B Q8WW43 1/20 0.39
NCSTN Q92542 1/20 0.39
APH1A Q96BI3 1/20 0.39
PSENEN Q9NZ42 1/20 0.39
EGFR P00533 1/20 0.39
NTRK1 P04629 1/20 0.39
ARAF P10398 1/20 0.39
PIM1 P11309 1/20 0.39
BRAF P15056 1/20 0.39
CSNK2A1 P68400 1/20 0.39
PIM3 Q86V86 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5357671 0.88 LRRK2 (0.51) LRRK2MDM2NTRK1MAPTHSP90AA1
SCHEMBL5369739 0.87 MAP1LC3B (0.43) LRRK2RAF1AURKAMAP1LC3BPLK4
SCHEMBL5367152 0.86 LRRK2 (0.48) LRRK2MDM2RAF1AURKAMAP1LC3B
SCHEMBL5361625 0.85 MDM2 (0.53) LRRK2MDM2NTRK1HSP90AA1RET
SCHEMBL7135667 0.83 LRRK2 (0.42) LRRK2MDM2RAF1AURKANTRK1
SCHEMBL5367223 0.81 CSNK1D (0.58) LRRK2MDM2PLK4PLK1GMNN
SCHEMBL5365871 0.81 PTPN1 (0.49) LRRK2MDM2PLK4PLK1PSEN1
SCHEMBL5376996 0.81 MEN1 (0.51) LRRK2MDM2PLK4PLK1MEN1
SCHEMBL5362198 0.81 LRRK2 (0.45) LRRK2MDM2RAF1MAP1LC3BPLK4
SCHEMBL5368885 0.80 KDM4E (0.47) LRRK2MDM2PLK4PLK1SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202265-B2 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. (US) 2007-04-10 US disclosed
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease FRK, PTK2, DSTYK LRRK2 289/4885MDM2 888/4885RAF1 245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.